Antimony resistance and environment: Elusive links to explore during Leishmania life cycle  by Sereno, Denis et al.
International Journal for Parasitology: Drugs and Drug Resistance 2 (2012) 200–203Contents lists available at SciVerse ScienceDirect
International Journal for Parasitology:
Drugs and Drug Resistance
journal homepage: www.elsevier .com/ locate/ i jpddrCurrent Opinion
Antimony resistance and environment: Elusive links to explore during
Leishmania life cycle
Denis Sereno a,⇑, Carla Maia b, Khatima Aït-Oudhia c
aMIVEGEC (UM1/UM2-CNRS5290-IRD224) Institut de Recherche pour le Développement (IRD), BP 64501, 34394 Montpellier Cedex 5, France
bUnidade de Parasitologia Médica (UPM), Centro de Malária e outras Doenças Tropicais (CMDT), Instituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa (UNL),
Rua da Junqueira, 100, 1349-008 Lisboa, Portugal
cEcole Nationale Supérieure Vétérinaire d’Alger, BP 161, Hassan Badi El-Harrach, Alger, Algeria
a r t i c l e i n f o a b s t r a c tArticle history:
Received 5 April 2012
Received in revised form 27 July 2012
Accepted 30 July 2012
Available online 3 September 2012
Keywords:
Leishmania
Drug resistance
Life cycle
Environment2211-3207  2012 Published by Elsevier Ltd. on beha
http://dx.doi.org/10.1016/j.ijpddr.2012.07.003
⇑ Corresponding author. Tel.: +33 4 67 41 63 28.
E-mail address: denis.sereno@ird.fr (D. Sereno).Leishmania drug resistance and particularly antimony resistance still continues to emerge in different
part of the world. Because visceral and cutaneous leishmaniasis are transmitted in foci with zoonotic
or anthroponotic life-cycles, the link between chemotherapeutic resistance and the selection for drug
resistance, through drug consumption, cannot be as obvious for all forms of leishmaniasis. The underlying
factors that trigger the selection of antimony resistant parasites are poorly studied in regard to environ-
mental aspects. Recently, a correlation between the emergence of antimony unresponsiveness in India
and water arsenic contamination has been raised. The presence of some yet unidentiﬁed environmental
factors driving the selection of antimony resistant Leishmania populations in a zoonotic context of leish-
maniasis is also currently questioned. The identiﬁcation of key molecules involved in the selection of
antimony resistance and their importance in the selective process have to be re-evaluated in light of
the environment were all the hosts of Leishmania (mammalian and arthropod) evolved. These new
insights will help to (i) address the risk of therapeutic failure associated with the emergence of drug-
resistance and (ii) propose new therapeutic protocols to aim at reducing the risk of resistance in endemic
areas.
 2012 Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc.
Open access under CC BY-NC-ND license.1. Introduction
Because antimony (Sb) compounds are the primary antileish-
manial drugs in most of developing countries, the emergence of
drug resistant strains in different parts of the world poses a public
health problem. To date, very little is known about the underlying
factors favoring the selection of Sb resistant Leishmania. It is as-
sumed that the therapeutic stress applied during leishmaniasis
treatment is the primary selective pressure that drives the selec-
tion of drug-resistant Leishmania. This point has been extensively
documented in various infectious models, but could be the tip of
the iceberg in Leishmania Sb resistance (Blower et al., 1996; Witte,
1998). A recent publication by Aït-Oudhia et al. (in press) con-
cludes that in an area where Sb pressure can be considered as
low or absent, in a zoonotic context of leishmaniasis, strains of
Leishmania infantum with very low antimony susceptibility can
be isolated from dogs at a relatively high frequency. Primary resis-
tance of L. infantum (syn. Leishmania chagasi) isolates among HIV
negative patients has also been recently documented (Inocêncio
da Luz et al., 2011). Furtheremore, in South America, in a contextlf of Australian Society for Parasitof zoonotic cutaneous leishmaniasis, Leishmania panamensis and
Leishmania braziliensis strains highly resistant to antimony were
isolated prior to patient treatment (Rojas et al., 2006). All these
recurrent observations suggest that some associated molecules
rather than Sb parenteral administration might be involved in
the selection of such antimony resistant strains (Aït-Oudhia
et al., 2011a, in press). Therefore, an integrated approach that in-
cludes identiﬁcation of key molecules of environmental or host de-
rived origins, as well as their sources and the parasitic stage they
act on, may shed light on the genesis of Leishmania drug resistance
in endemic foci. These will help to identify potential ‘‘hot spot’’ of
antimony resistance.2. Leishmania life cycle and selective pressure
Visceral and cutaneous leishmaniasis are transmitted in foci
with zoonotic or anthroponotic life-cycles, implying that all the
hosts that Leishmania colonizes, as well as the environment that
surround these hosts can be highly divergent. Therefore, a link be-
tween drug consumption and selection of drug resistant parasites
may not be as obvious for leishmaniasis as for other microorgan-
isms (see Fig. 1).ology Inc. Open access under CC BY-NC-ND license.
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donovani and most foci of Leishmania tropica, parasites are trans-
mitted from patients to patients by the bite of a sandﬂy. In zoo-
notic forms of leishmaniasis, that include different cutaneous or
mucocutaneous leishmaniasis, parasites are transmitted to pa-
tients by sandﬂies from a reservoir host, represented by domestic
or wild mammals. In this context, the main chemotherapeutic
pressure that Leishmaniawill encouter will be during the treatment
of individuals, with the exception of zoonotic leishmaniasis caused
by L. infantum. In this visceral form of the disease, the therapeutic
pressure is applied on a population of parasites that is not trans-
mitted, because humans are generally not considered as a reservoir
for L. infantum, with the exeption for HIV/Leishmania co-infection
(Molina et al., 1999). Dogs are the main domestic and peridomestic
reservoir host of L. infantum. In the occidental part of the Mediter-
ranean (France, Italy, Spain, Portugal. . .), dogs are treated with the
same drugs used to treat human leishmaniasis, while this is not
supposed to occur. Infected dogs never achieve parasitological
cure, even when their health improves. This, in conjunction with
the high percentage of animals that will relapse and repeatedly
be treated with the same compound, makes antimony resistant
parasites selection and transmission possible (Campino and Maia,
2012). Contradictory results have been obtained in the very few
studies made to evaluate the susceptibility to antimonials of L.
infantum strains isolated from treated and untreated dogs. While
Carrio and Portus (2002) did not ﬁnd any differences between iso-
lates coming from treated and untreated dogs, others reported a
decreased in vitro sensitivity to Sb during and after several treat-
ment courses (Gramiccia et al., 1992). In fact, the risk of emergence
and spread of resistant parasites in the canine and human popula-
tions should not be neglected, especially when dogs and humans
are treated with the same drugs.
Overall, in anthroponotic foci and is some peculiar cases of zoo-
notic visceral leishmaniasis, the antimony administered duringNO
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Fig. 1. Origin of potential selective agents in the context of anthroponotic and zoonot
between various host and have two main morphological forms: intracellular amastigote
agents that operate to select Sb resistance are present at each parasitic stage. They can
antimony therapy (b) and/or from host derived microbicidal factors (c). All of them ca
leishmaniasis caused by L. infantum, the agent responsible for the visceral form of the d
considered as reservoir except in Leishmania HIV co-infection where transmission from hu
with antimonials. In anthroponotic forms of the disease, humans represent the principal
accomplish their intravectorial development in the lumen of the sandﬂy gut and heavy
feeding. Antimony or other metal ions like arsenic can reach Leishmania amastigotes in m
microbicidal molecules also involved in the mode of actions of metal ions like hydroge
resistant parasites. The production of these molecules can be induced in the sandﬂy, at t
mammalian reservoir host.treatment represent a major selective agent for drug-resistant
parasites (Fig. 1).
3. Interplay between environmental and host derived selective
agents
In many infectious diseases and more particularly in bacterial
borne diseases, the emergence of resistance to antibiotics in previ-
ously susceptible pathogens is challenging to medicine. There is
now a growing body of evidence demonstrating that environmen-
tal microbes are highly drug resistant and that the antibiotic resis-
tance genes have the potential to be transferred to pathogenic
bacteria via horizontal gene transfer. These genes then evolved un-
der the strong antibiotic selective pressure that occurs during the
treatment of infections (Reviewed in Martinez, 2009; Wright,
2010). In bacteria, the elements involved in the resistance to heavy
metals are present in bacterial strains like Ralstonia metallidurans
(Mergeay et al., 2003), which are well adapted for surviving in nat-
urally heavy metals-rich habitats (e.g. volcanic soils). The strong
selective pressure due to anthropogenic pollution has made that
chromosomally-encoded determinants for heavy metal resistance
are now present in gene transfer units, so they can efﬁciently
spread among bacterial populations (Silver and Phung, 1996,
2005; Nies, 2003). Nonetheless exposure to environmental chemi-
cals is certainly not a contemporary phenomenon as bioactive
chemical diversity is certainly ancient and vast.
Leishmania parasite does not evolve in naturally heavy metal
rich environment. However, in heavily polluted areas, such as min-
ing sites, swamps and urban environments, sandﬂies feed on plants
that could be contaminated by local atmospheric dust, and wild or
feral animal reservoirs that can be exposed to heavy metal such as
Sb and Arsenic (As), by drinking polluted water. Concentrations up
to 3 mg/l of Sb have been reported in some natural sources (Krach-
ler et al., 2005; Shotyk et al., 2005a,b). The presence of As or Sb inr arsenic
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ic life cycles of Leishmania. During its life cycle of Leishmania alternates (arrows)
s in the mammalian hosts and motile promastigotes in the sandﬂy vector. Selective
originate from the environment (a), the chemotherapeutic pressure applied during
n select Leishmania parasites with low antimony susceptibility. In zoonotic foci of
isease, mammalian hosts can be wild or domestic (cats or dogs). Humans are not
man to sandﬂy is documented (dashed arrows). In these cases, only dogs are treated
reservoir host for Leishmania amastigotes. In the sandﬂy, Leishmania promastigotes
metals of environmental origin can reach promastigotes parasites during sandﬂy
ammals when they drink water in polluted environment. In addition, host derived
n peroxide (H2O2) or nitric oxide (NO), can contribute to the selection of antimony
he level of the intestinal gut epithelium, and in the host cells of Leishmania in their
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tive agent involved in antimony resistance selection (Aït-Oudhia
et al., 2011a). Likewise, the information given by Perry et al.
(2011) is suggestive of the role play by As groundwater contamina-
tion on the emergence of decreased antimonial efﬁcacy in India. In
this country, mass arsenic poisoning was identiﬁed in the 1980s
and preceded the emergence of decreased antimony efﬁcacy. If
veriﬁed, this hypothesis will be the ﬁrst factual evidence of the
involvement of factors present in the environment during the
selection of antimony resistant Leishmania. In fact arsenic and anti-
monial are metalloids that share many common structural and
chemical properties and it has long been recognized that selection
of Leishmania for arsenic resistance led to antimony cross-resis-
tance (Rosen, 1995). To understand if arsenic pollution has trig-
gered antimony resistance will be far from easy, because no
strains representative of the pre-arsenic contamination period, be-
fore the 1980s, are present in cryobanks and because no speciﬁc
markers for arsenic resistance are available. Therefore it will be dif-
ﬁcult to determine whether arsenic pressure through water con-
tamination or antimony pressure applied during chemotherapy
underlie the selection of antimony resistance (Fig. 1).
Besides the presence of antimony in the ecosystem where Leish-
mania take place, several host derived microbicidal molecules such
as nitric oxide (NO) or reactive oxygen species (ROS) might also
contribute to shape antimony susceptibility in natural Leishmania
populations. These molecules play a role in the in vivo leishmani-
cidal activity of antimony formulations (Carter et al., 2005; Moo-
kerjee-Basu et al., 2006; Mandal et al., 2007; Sarkar et al., 2011)
and mediate the cytotoxic effect of metal ions, like As (Valko
et al., 2005). Leishmania resistance to NO involves trypanothione
metabolism, which is crucial for antimony resistance (Bocedi
et al., 2010). Experimental evidence supports the notion that NO
may be a crucial factor that can modify the antimony response of
Leishmania populations. Axenic amastigotes of Leishmania that
were selected in vitro for SbIII-resistance are cross-resistant to As
(unpublished results) and expressed a cross-resistance to NO
(Holzmuller et al., 2005). Although up to now no studies have ad-
dressed the effect that NO resistance has on antimony cross-resis-
tance, it was shown/observed that L. braziliensis promastigotes
isolated from antimony-unresponsive patients were generally less
susceptible to NO (Souza et al., 2010).
Altogether, the environment that Leishmania encounters all over
its life cycle might play a more important role for drug resistance
selection in zoonotic context of leishmaniasis than in anthroponot-
ic ones, even if they can also in part contribute to drug resistance
emergence in both situations.
4. Concluding remarks
The therapeutic arsenal used for the treatment of leishmaniasis
is limited. Besides antimony containing drugs, like Pentostam or
Glucantime, amphotericin B, pentamidine and miltefosine are
also used. No cross-resistance between antimony and other antile-
ishmanial molecules was detected in in vitro selected antimony
resistant mutant (Sereno et al., 2001) or in naturally resistant L.
tropica and L. major (Hadighi et al., 2007). A cross resistance be-
tween antimony and amphotericin B or miltefosine was detected
in naturally resistant L. donovani parasites and has been experi-
mentally linked to the overexpression of the histone H2A (Kumar
et al., 2009; Singh et al., 2010). Altogether these observations rein-
force our opinion on the crucial importance of understanding the
selective factors triggering Leishmania drug resistance in natura,
in order to limit its spread.
Recently, a superior ﬁtness of clinical resistant strains has been
documented for antimony resistant ﬁeld isolates of L. donovani
(Vanaerschot et al., 2010). These observations contrast with thein vitro selected parasites where ﬁtness and competitive costs are
associated with drug resistance (Agnew et al., 2001; Sereno et al.,
2001; Aït-Oudhia et al., 2011b).
The next years will be important to deﬁne the diversity and the
relative importance of environmental factors that play a role in the
selection of antimony resistant Leishmania in endemic areas. These
ﬁnding will help to better understand the risk of therapeutic failure
associated with the emergence of drug-resistance and streamline
the development of novel therapeutic protocols aiming at decreas-
ing the risk of selection of resistant strains.
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